In Vitro Drug-Drug Interaction Potential of Sulfoxide and/or Sulfone 
Metabolites of Albendazole, Triclabendazole, Aldicarb, Methiocarb, Montelukast and Ziprasidone

por Giri, Poonam, Gupta, Lakshmikant, Naidu, Sneha, Joshi, Vipul, Patel, Nirmal, Giri, Shyamkumar, Srinivas, Nuggehally R.
Publicado 2018

Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor

por Agarwal, Sameer, Pethani, Jignesh P., Shah, Hardik A., Vyas, Vismit, Sasane, Santosh, Bhavsar, Harsh, Bandyopadhyay, Debdutta, Giri, Poonam, Viswanathan, Kasinath, Jain, Mukul R., Sharma, Rajiv
Publicado 2020

ZYBT1, a potent, irreversible Bruton’s Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer

por Ghoshdastidar, Krishnarup, Patel, Hoshang, Bhayani, Hitesh, Patel, Ankit, Thakkar, Kinjal, Patel, Dinesh, Sharma, Manoranjan, Singh, Jaideep, Mohapatra, Jogeswar, Chatterjee, Abhijit, Patel, Dipam, Bahekar, Rajesh, Sharma, Rajiv, Gupta, Lakshmikant, Patel, Nirmal, Giri, Poonam, Srinivas, Nuggehally R., Jain, Mukul, Bandyopadhyay, Debdutta, Patel, Pankaj R., Desai, Ranjit C.
Publicado 2020